MSD
The Distinguished Scientist serves as a Drug Metabolism and Pharmacokinetics (DMPK) submission expert, ensuring consistent quality filings from first-in-human studies through marketing applications and life-cycle management. This leader supports the PDMB portfolio strategy across therapeutic areas and modalities, providing scientific oversight for nonclinical PK packages and contributing to regulatory filings and labeling discussions. The role involves influencing portfolio decisions, mentoring future leaders, and collaborating with cross-functional teams to advance drug development candidates.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago
Sr. Principal Scientist / Director, DMPK & Bioanalytical Sciences
Alltrna
Sr. Principal Scientist / Director, DMPK & Bioanalytical Sciences
Flagship Pioneering, Inc.
Director of DMPK
wattonhall
Director, Pharmacokinetics
Merck & Co., Inc.
Sr Director, Drug Metabolism
Gilead Sciences
Director, Translational Science/Pharmacokinetics
Tarsus Pharmaceuticals